Quantitative exposure assessment: application of physiologically-based pharmacokinetic (PBPK) modeling of low-dose, long-term exposures of organic acid toxicant in the brain

By Kim C.S.   Sandberg J.A.   Slikker W.   Binienda Z.   Schlosser P.M.   Patterson T.A.  

Environmental Toxicology and Pharmacology, Vol. 9, Iss. 4, 2001-03 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic Modeling of Benzene Metabolism in Mice Through Extrapolation from In Vitro to In Vivo

By Cole Cammey E.   Tran Hien T.   Schlosser Paul M.  

Journal of Toxicology and Environmental Health, Vol. 62, Iss. 6, 2001-03 ,pp. : 439-465

Taylor & Francis Ltd

Access to resources Recommend Favorite

Quantitative low-dose assessment of seafood toxin, domoic acid, in the rat brain: application of physiologically-based pharmacokinetic (PBPK) modeling

By Kim C.S.   Ross I.A.   Sandberg J.A.   Preston E.  

Environmental Toxicology and Pharmacology, Vol. 6, Iss. 1, 1998-08 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

By Kirman C.R.   Sweeney L.M.   Meek M.E.   Gargas M.L.  

Regulatory Toxicology and Pharmacology, Vol. 38, Iss. 3, 2003-12 ,pp. : 345-367

Elsevier

Access to resources Recommend Favorite

Impact of Physiologically Based Pharmacokinetic Modeling on Benchmark Dose Calculations for TCDD-Induced Biochemical Responses

By Kim A.H.   Kohn M.C.   Portier C.J.   Walker N.J.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 287-296

Academic Press

Access to resources Recommend Favorite